Skip to main content
. 2022 Dec 30;145(2):1136–1143. doi: 10.1021/jacs.2c10819

Figure 2.

Figure 2

(A) Time-dependent killing by 3 of MRSA USA300. (B) Resistance development of MRSA USA300 against 3 and daptomycin during daily serial passaging with 0.25× MIC concentrations.